D
Delfina
Intelligent pregnancy care for healthier moms and babies
About Delfina
Delfina is a health-tech startup that operates in the maternal health sector. The company's primary offering is a data-driven care management platform, Delfina Care, which is designed to cater to the diverse needs of pregnant individuals and their healthcare providers. The platform uses clinically validated AI algorithms to predict and prevent pregnancy complications, thereby enhancing the overall health outcomes for both mother and baby.
Read full description
Delfina's business model revolves around partnering with employers and healthcare providers. The company offers specialized benefits for expecting parents and families, aiming to boost employee satisfaction and productivity. Delfina supplements traditional healthcare plans with its unique AI-enabled offering, striving to improve the care experience for all pregnant members and their families.
The company's platform also includes an immersive app that provides personalized patient education, telehealth services, and health tracking through remote patient monitoring. This allows care teams to gain continuous insights from the AI-driven Provider Dashboard, which integrates data from multiple sources to assess patient risk for pregnancy complications. This dual support system reassures patients that their providers are well-informed and allows providers to make data-driven decisions.
Delfina operates in a market that is increasingly recognizing the importance of personalized and data-driven healthcare. The company's revenue model likely involves service fees from employers and healthcare providers who use their platform.
At a glance
- Status
- Operational
- Founded
- 2020
- Headquarters
- San Francisco, United States
- Employees
- 220
- Open positions
- None listed
- Dealroom signal
- 87.5/100
- Industry
- Health
- Sub-industry
- Health Platform
- Sector
- Health Tech & Medtech, Hard Tech
- Business model
- Marketplace & ecommerce
- Client focus
- b2b, b2c
Latest news
Press, funding announcements and product moves mentioning Delfina.
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES A✓Equity / VC | Jan 2025 | $17M | $68M | Artis Ventures · Story Ventures · Bread and Butter Ventures · SemperVirens VC | ↗ |
| SEEDEquity / VC | Aug 2022 | — | — | Mayo Clinic Platform | ↗ |
Financials
Revenue, earnings and other financial measures where available. Years marked “E” are estimates.
Growth signals
Latest recorded traffic for Delfina is 8.8K monthly website visits, up 41.9% over the last three months. Delfina's team grew 10% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed2 investors entered at this stage
Harvard Innovation Labs
Mayo Clinic Platform
Series A14 investors entered at this stage
Story Ventures
E14 Fund
Goodwater Capital
Hugo Barra
SpringTime Ventures
Bread and Butter Ventures
SemperVirens VC
Ellen Pao- MVMetrodora Ventures
U.S. Venture Partners
Artis Ventures
Tokio Marine Future Fund
Mayo Clinic
Boutique Venture Partners
Other known investors3 additional known investors
MassChallenge
Matchstick Ventures
Synetro Group
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Delfina on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Delfina’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.